The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.

Completed

Conditions studied: Bony Metastases From Castrate Refractory Prostate Cancer

In brief

To describe the changes seen on bone scan and correlate them with changes in relative chemical biomarkers, patient's functional status and level of pain.

Key facts

Study ID

NCT03368989

Run by

The University of Texas Health Science Center, Houston

People needed

21

Starts

2014-02-11

Expected to finish

2017-02-07

Last updated by the study team

2019-06-11

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Prostate cancer patients scheduled for treatment with Radium-223.

You may not qualify if…

• Patients not completing their treatment regimen for any reason

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.